- Home
- NMG vs ARCT Comparison
NMG vs ARCT Comparison
Compare NMG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- ARCT
- Stock Information
- Founded
- NMG 2011
- ARCT 2013
- Country
- NMG Canada
- ARCT United States
- Employees
- NMG N/A
- ARCT N/A
- Industry
- NMG Other Metals and Minerals
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- NMG Basic Materials
- ARCT Health Care
- Exchange
- NMG Nasdaq
- ARCT Nasdaq
- Market Cap
- NMG 448.1M
- ARCT 526.5M
- IPO Year
- NMG 2017
- ARCT N/A
- Fundamental
- Price
- NMG $2.45
- ARCT $8.93
- Analyst Decision
- NMG Strong Buy
- ARCT Buy
- Analyst Count
- NMG 3
- ARCT 10
- Target Price
- NMG $4.22
- ARCT $35.25
- AVG Volume (30 Days)
- NMG 1.9M
- ARCT 2.2M
- Earning Date
- NMG 11-14-2025
- ARCT 11-10-2025
- Dividend Yield
- NMG N/A
- ARCT N/A
- EPS Growth
- NMG N/A
- ARCT N/A
- EPS
- NMG N/A
- ARCT N/A
- Revenue
- NMG N/A
- ARCT $122,122,000.00
- Revenue This Year
- NMG N/A
- ARCT N/A
- Revenue Next Year
- NMG N/A
- ARCT $34.32
- P/E Ratio
- NMG N/A
- ARCT N/A
- Revenue Growth
- NMG N/A
- ARCT N/A
- 52 Week Low
- NMG $1.22
- ARCT $8.04
- 52 Week High
- NMG $6.06
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- NMG 41.82
- ARCT 29.52
- Support Level
- NMG $2.75
- ARCT $9.36
- Resistance Level
- NMG $3.60
- ARCT $10.12
- Average True Range (ATR)
- NMG 0.42
- ARCT 1.27
- MACD
- NMG -0.12
- ARCT -0.85
- Stochastic Oscillator
- NMG 8.36
- ARCT 0.59
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.